glp-1 agonists and sglt2 inhibitors Criteria for recommendation of or receptor Cardiovascular benefits of SGLT2 inhibitors
Description
GIP adds metabolic improvements through pancreatic and fat tissue effects
8.0%, hazard ratio [HR]: 0.80, 95% CI 0.72, 0.90)
Poornima, I
On the other hand, product uptake is through the roof
The disease can lead to numerous complications including damage to the heart and blood vessels, kidney disease, eye disease, nerve damage and premature death
